In a notice on its website, the European Medicines Agency also announced the withdrawal, which means that Vaxzevria is no longer authorized to be marketed or sold in European Union countries.
The most widely circulating COVID variant worldwide is now JN.1, having overtaken the XBB family that is the target of the most recent vaccines, the European Medicines Agency said.
...genomic surveillance could do much more to reduce the toll of disease and death worldwide than just protect us from COVID-19. Writing inFrontiers in Science, an international collective of clinical and public health microbiologists from the European Society for Clinical Microbiology and Infectious Diseases (ESCMID) calls for investment in technology, capacity, expertise, and collaboration to put genomic surveillance of pathogens at the forefront of future pandemic preparedness.
A new study based on German data shows that SARS-CoV-2 caused a 21% excess of acute respiratory infections (ARIs) during the winter of 2022-23. The study was published this week in the International Journal of Infectious Diseases and suggests COVID-19 will add a significant burden during cold and flu seasons.
Recent Comments